Tag: Prescription Drugs
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer
HER2-low is a new classification for a subset of HER2-negative breast cancer
Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease
Two studies show lack of benefit in primary or secondary end points with cinpanemab or prasinezumab versus placebo
Many Online Pharmacies Sell Imatinib Without Prescription
23 percent of pharmacies selling imatinib online did not include drug-related warnings on their websites
Prasterone Studied for Treatment of Urinary Urge Incontinence
Observational study suggests symptoms of urinary urge incontinence reduced in postmenopausal women using prasterone
Effect of Noradrenergic Drugs Explored in Alzheimer Disease
Meta-analyses suggest positive effects of noradrenergic drugs on global cognition, apathy
OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained
Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab
Out-of-Pocket Costs for Epinephrine Auto-Injectors Examined
Cost-sharing still substantial for some using nonbranded auto-injectors, such as those enrolled in high-deductible health plans
Pembrolizumab Ups Survival in Advanced Triple-Negative Breast Cancer
Overall survival longer with addition of pembrolizumab to chemo in tumors expressing PD-L1 with combined positive score of 10 or more
NAMS Updates Position Statement on Menopausal Hormone Therapy
Using best available evidence, treatment should be individualized to maximize benefits and minimize risks
FDA Approves First Topical Treatment for Vitiligo
Opzelura can be used twice daily in patients ages 12 years and older
